The main goal of a PET-CT for prostate cancer is to detect cancerous lesions that express prostate-specific membrane antigen (PSMA). The PSMA PET-CT in Israel offers high sensitivity and accuracy, making it an essential part of prostate cancer staging in Israel and follow-up evaluations.
PSMA PET-CT for Prostate Cancer
Purpose of the Scan
Preparation for the Scan
To ensure the best results, patients must bring a recent PSA blood test and their Gleason score evaluation. These parameters help in personalizing the imaging protocol for prostate cancer imaging in Israel.
Patients are asked to arrive on time, as the radiopharmaceutical agent used during the scan, PET 68Ga-PSMA in Israel, has a short half-life and must be administered precisely. In case of delay, a lower dose might be used, affecting image quality.
There is no special dietary preparation required. Patients may take their regular medications unless otherwise advised. The total time spent at the Nuclear Medicine Center is about 3 hours.
Scan Process
Upon arrival, patients are checked in and receive a consultation with a physician and nurse. A venous catheter is inserted, and the 68Ga PSMA PET-CT radiotracer is administered.
After about 45 minutes of rest in isolation, the scan is performed. The scanning process itself takes approximately 20 minutes. If needed, a contrast agent may also be administered intravenously during the imaging.
Advantages and Access
The no wait PSMA scan policy ensures quick access to diagnostics, often within just a few days of referral. This is especially critical for patients requiring fast staging and treatment planning. For international patients seeking PSMA PET-CT without waiting, our center offers efficient coordination and support throughout the diagnostic journey.
To receive care from one of the best hospitals in Israel, email us at medtour@tlvmc.gov.il or submit a request on the official website of the Ichilov Medical Center. Our specialists will contact you within 24–48 hours.